IgY industries and markets

Ricardo S. Vieira-Pires, Hyeong Chul Ahn, Marina Bok, Catherine D. Caulfield, Pablo Chacana, Fazle Elahi, Anders O. Larsson, Carlos Leónidas Leiva, Leonard M. Moran, Patricia M. Morgan, Viviana Parreño, Celina G. Vega, Andrés Wigdorovitz

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Citations (Scopus)

Abstract

Applications of the knowledge of avian IgY biology from establishing proof-of-concept studies to the formation of new industries and markets has been very poorly documented. It is particularly relevant to clearly present to a broader audience the real-world companies and industries that are translating the unique capabilities of birds and their antibodies into new products and services with worldwide impact. Herein we showcase a selection of what we termed IgY companies and elucidate how these are exploiting opportunities in areas such as biopharmaceuticals, functional foods or cosmetics, animal nutrition, large scale IgY manufacture or even vaccine production. A brief overview of the current IgY-technology intellectual property landscape and its peculiarities is also presented.

Original languageEnglish
Title of host publicationIgY-Technology
Subtitle of host publicationProduction and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice
PublisherSpringer International Publishing
Pages279-308
Number of pages30
ISBN (Electronic)9783030726881
ISBN (Print)9783030726867
DOIs
Publication statusPublished - 24 Jun 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Springer Nature Switzerland AG 2021. All rights reserved.

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Keywords

  • Biopharmaceuticals
  • Human and animal health
  • Immunoprophylaxis and immunodiagnosis
  • Intellectual property
  • Large-scale IgY manufacture
  • Vaccines

Fingerprint

Dive into the research topics of 'IgY industries and markets'. Together they form a unique fingerprint.

Cite this